1
|
Sollini ML, Pellegrino C, Barone G, Capitanucci ML, Zaccara AM, Crescentini L, Castelli E, Della Bella G, Scorletti F, Papetti L, Monte G, Ferilli MAN, Valeriani M, Mosiello G. Lower Urinary Tract Dysfunction in Pediatric Patients with Multiple Sclerosis: Diagnostic and Management Concerns. CHILDREN (BASEL, SWITZERLAND) 2024; 11:601. [PMID: 38790596 PMCID: PMC11119741 DOI: 10.3390/children11050601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2024] [Revised: 05/10/2024] [Accepted: 05/15/2024] [Indexed: 05/26/2024]
Abstract
BACKGROUND Multiple sclerosis (MS) is increasing in the pediatric population and, as in adults, symptoms vary among patients. In children the first manifestations can sometimes overlap with acute neurological symptoms. Urological symptoms have not been much studied in childhood. We shared our experience with MS urological manifestation in children. METHODS This article is a retrospective evaluation of all children with MS, according to the Krupp criteria, who also present with urological symptoms. We collected demographic and clinical history, the MR localization of demyelinating lesions, urological symptoms, and exams. RESULTS We report on six MS pediatric cases with urological manifestation. Urinary symptoms, characterized by urinary incontinence in five patients and urinary retention in one patient, appeared in a different time frame from MS diagnosis. Urodynamic exams showed both overactive and underactive bladder patterns. Treatment was defined according to lower urinary tract dysfunction, using clean intermittent catheterization, oxybutynin, and intradetrusor Onabotulinum Toxin-A injection. A low acceptance rate of invasive evaluation and urological management was observed. CONCLUSIONS The MS diagnosis was traumatic for all our patients. We believe it is important to address urological care in young people from the time of diagnosis for prompt management; it could be useful to include a pediatric urologist in multidisciplinary teams.
Collapse
Affiliation(s)
- Maria Laura Sollini
- Division of Neuro-Urology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.L.S.); (G.B.); (M.L.C.); (A.M.Z.); (L.C.); (G.M.)
- Clinical Science and Translational Medicine, Tissue Engineering and Remodeling Biotechnologies for Body Function PhD School, University of Rome Tor Vergata, Via Cracovia 50, 00133 Rome, Italy
| | - Chiara Pellegrino
- Division of Neuro-Urology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.L.S.); (G.B.); (M.L.C.); (A.M.Z.); (L.C.); (G.M.)
| | - Giulia Barone
- Division of Neuro-Urology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.L.S.); (G.B.); (M.L.C.); (A.M.Z.); (L.C.); (G.M.)
- Pediatric Surgery, University of Genoa, DINOGMI, Largo Paolo Daneo 3, 16132 Genoa, Italy
| | - Maria Luisa Capitanucci
- Division of Neuro-Urology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.L.S.); (G.B.); (M.L.C.); (A.M.Z.); (L.C.); (G.M.)
| | - Antonio Maria Zaccara
- Division of Neuro-Urology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.L.S.); (G.B.); (M.L.C.); (A.M.Z.); (L.C.); (G.M.)
| | - Leonardo Crescentini
- Division of Neuro-Urology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.L.S.); (G.B.); (M.L.C.); (A.M.Z.); (L.C.); (G.M.)
| | - Enrico Castelli
- Neurorehabilitation Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy;
| | - Gessica Della Bella
- Neurorehabilitation and Adapted Physical Activity Day Hospital, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy;
| | - Federico Scorletti
- Neonatal Surgery Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy;
| | - Laura Papetti
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (L.P.); (G.M.); (M.A.N.F.); (M.V.)
| | - Gabriele Monte
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (L.P.); (G.M.); (M.A.N.F.); (M.V.)
| | - Michela Ada Noris Ferilli
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (L.P.); (G.M.); (M.A.N.F.); (M.V.)
| | - Massimiliano Valeriani
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (L.P.); (G.M.); (M.A.N.F.); (M.V.)
| | - Giovanni Mosiello
- Division of Neuro-Urology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.L.S.); (G.B.); (M.L.C.); (A.M.Z.); (L.C.); (G.M.)
| |
Collapse
|
2
|
Faustino R, Lopes C, Jantarada A, Mendonça A, Raposo R, Ferrão C, Freitas J, Mateus C, Pinto A, Almeida E, Gomes N, Marques L, Palavra F. Neuroimaging characterization of multiple sclerosis lesions in pediatric patients: an exploratory radiomics approach. Front Neurosci 2024; 18:1294574. [PMID: 38370435 PMCID: PMC10869542 DOI: 10.3389/fnins.2024.1294574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Accepted: 01/15/2024] [Indexed: 02/20/2024] Open
Abstract
Introduction Multiple sclerosis (MS), a chronic inflammatory immune-mediated disease of the central nervous system (CNS), is a common condition in young adults, but it can also affect children. The aim of this study was to construct radiomic models of lesions based on magnetic resonance imaging (MRI, T2-weighted-Fluid-Attenuated Inversion Recovery), to understand the correlation between extracted radiomic features, brain and lesion volumetry, demographic, clinical and laboratorial data. Methods The neuroimaging data extracted from eleven scans of pediatric MS patients were analyzed. A total of 60 radiomic features based on MR T2-FLAIR images were extracted and used to calculate gray level co-occurrence matrix (GLCM). The principal component analysis and ROC analysis were performed to select the radiomic features, respectively. The realized classification task by the logistic regression models was performed according to these radiomic features. Results Ten most relevant features were selected from data extracted. The logistic regression applied to T2-FLAIR radiomic features revealed significant predictor for multiple sclerosis (MS) lesion detection. Only the variable "contrast" was statistically significant, indicating that only this variable played a significant role in the model. This approach enhances the classification of lesions from normal tissue. Discussion and conclusion Our exploratory results suggest that the radiomic models based on MR imaging (T2-FLAIR) may have a potential contribution to characterization of brain tissues and classification of lesions in pediatric MS.
Collapse
Affiliation(s)
- Ricardo Faustino
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
- Faculty of Science, Institute of Biophysics and Biomedical Engineering, University of Lisbon, Lisbon, Portugal
- Biomedical Research Group, Faculty of Engineering, Faculty of Veterinary Medicine NICiTeS, Lusófona University, Lisbon, Portugal
| | - Cristina Lopes
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Afonso Jantarada
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Ana Mendonça
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Rafael Raposo
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Cristina Ferrão
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Joana Freitas
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Constança Mateus
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Ana Pinto
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Ellen Almeida
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Nuno Gomes
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Liliana Marques
- Neuroimaging and Biomedicine Research Group, Medical Imaging and Radiotherapy Research Unit, CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal
| | - Filipe Palavra
- Centre for Child Development – Neuropediatrics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
- Laboratory of Pharmacology and Experimental Therapeutics, Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research, University of Coimbra, Coimbra, Portugal
- Clinical Academic Center of Coimbra, Coimbra, Portugal
| |
Collapse
|
3
|
Tarantino S, Proietti Checchi M, Papetti L, Monte G, Ferilli MAN, Valeriani M. Parental Experiences in Pediatric Multiple Sclerosis: Insights from Quantitative Research. CHILDREN (BASEL, SWITZERLAND) 2024; 11:71. [PMID: 38255384 PMCID: PMC10814813 DOI: 10.3390/children11010071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Revised: 12/31/2023] [Accepted: 01/04/2024] [Indexed: 01/24/2024]
Abstract
Multiple sclerosis (MS) is a chronic and unpredictable inflammatory disease impacting the central nervous system. The disabling nature of this disease is not limited to only physical symptoms. MS, even at a pediatric age, often includes cognitive impairment, fatigue, and psychological issues, affecting education and social life, causing emotional distress, and reducing quality of life. Despite the paucity of quantitative data in the existing literature, our review demonstrates that the impact of pediatric MS extends beyond the patients themselves, affecting their parents as well. There is evidence suggesting that having a child with MS may be associated with a reduction in the parental quality of life, even in families of MS patients with low or no disability and without clinical relapses. Moreover, an increased risk of parents' mental illness has been described, particularly in mothers, leading to a heightened utilization of mental health services. Research data show that inadequate information about MS may impact parents' anxiety and their sense of competence. Since parents' involvement has been found to also play a role in their child's adherence to treatment, special attention should be paid to parental psychological health. Additional research exploring family adaptation to their children's illness is required.
Collapse
Affiliation(s)
- Samuela Tarantino
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00165 Rome, Italy (L.P.); (M.V.)
| | - Martina Proietti Checchi
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00165 Rome, Italy (L.P.); (M.V.)
| | - Laura Papetti
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00165 Rome, Italy (L.P.); (M.V.)
| | - Gabriele Monte
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00165 Rome, Italy (L.P.); (M.V.)
| | - Michela Ada Noris Ferilli
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00165 Rome, Italy (L.P.); (M.V.)
| | - Massimiliano Valeriani
- Developmental Neurology Unit, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00165 Rome, Italy (L.P.); (M.V.)
- Systems Medicine Department, Tor Vergata University of Rome, 00133 Rome, Italy
- Center for Sensory-Motor Interaction, Aalborg University, 9220 Aalborg, Denmark
| |
Collapse
|